Auropharma BULLISH Auropharma 75 minutes chart.. formed higher low . .. upward movement of 5 to 8%.. targets mentioned
Aurobindo Pharma Ltd
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
58.95 INR
34.86 B INR
314.03 B INR
278.94 M
About Aurobindo Pharma Ltd
Sector
Industry
CEO
Kambam Nithyananda Reddy
Website
Headquarters
Hyderabad
Founded
1986
IPO date
Jan 19, 1995
Identifiers
2
ISIN INE406A01037
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Related stocks
AuropharmaNow the pharma sector is showing some move after a long consolidation. One can look for longs in Auropharma as it has given a breakout of a falling trendline and is coming out of a range.
Entry- 1253-1255
Support- 1225/1220
Target- 1280, 1300
Declaimer- This is just for educational purpose.
JAI
Aurobindo Pharma Weekly Setup: 9%–73% Swing Upside in FocusNSE:AUROPHARMA Aurobindo Pharma presents a potential upside ranging from ~9% to ~73%, calculated from the safe entry above ₹1,260 to Target 1 near ₹1,592, and extending toward the Swing Trade Target around ₹2,174. The weekly chart highlights a base-formation after a corrective phase, setting the st
#AUROPHARMA - 783 or 1465? 300 Points Move?Date: 23-09-2025
#AUROPHARMA Current Price: 1109.9
Pivot Point: 1124 Resistance: 1179 Support: 1070
Upside Levels:
Upside Level 1: 1249
Upside Level 2: 1319
Upside Level 3: 1392
Upside Level 4: 1465
Downside Levels:
Down side Level 1:
Keep on radar.After forming a base now its close to resistance , can be a good breakout candidate, worth keep track.
AUROPHARMAMy View on the Chart AUROPHARMA
Entry Point: On retest of the green line
Stop Loss: Strictly at the red line
The price has broken out above a key resistance level, which may indicate a potential bullish trend continuation. In my view, a retest of the green line could offer a good entry opportunit
AUROPHARMA MOVE from gapAUROPHARMA, how gap works and enter in stock. this is recent exp. learn and earn
auro pharma auro pharma creating a different aura , near to breaking out the consolidation zone.
once cross and hold above resistance line than a good move expected over the counter.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AUROPHARMA is 1,191.00 INR — it has increased by 0.80% in the past 24 hours. Watch Aurobindo Pharma Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Aurobindo Pharma Ltd stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has risen by 0.08% compared to the previous week, the month change is a −3.67% fall, over the last year there was no change in Aurobindo Pharma Ltd price.
We've gathered analysts' opinions on Aurobindo Pharma Ltd future price: according to them, AUROPHARMA price has a max estimate of 1,640.00 INR and a min estimate of 1,050.00 INR. Watch AUROPHARMA chart and read a more detailed Aurobindo Pharma Ltd stock forecast: see what analysts think of Aurobindo Pharma Ltd and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on Sep 13, 2024 with the price of 1,592.00 INR, and its all-time low was 4.60 INR and was reached on Jan 4, 1999. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 2.56% volatile and has beta coefficient of 1.47. Track Aurobindo Pharma Ltd stock price on the chart and check out the list of the most volatile stocks — is Aurobindo Pharma Ltd there?
Today Aurobindo Pharma Ltd has the market capitalization of 691.82 B, it has decreased by −0.48% over the last week.
Yes, you can track Aurobindo Pharma Ltd financials in yearly and quarterly reports right on TradingView.
Aurobindo Pharma Ltd is going to release the next earnings report on Feb 9, 2026. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 14.61 INR per share, whereas the estimation was 15.24 INR resulting in a −4.15% surprise. The estimated earnings for the next quarter are 15.94 INR per share. See more details about Aurobindo Pharma Ltd earnings.
Aurobindo Pharma Ltd revenue for the last quarter amounts to 82.86 B INR, despite the estimated figure of 81.42 B INR. In the next quarter, revenue is expected to reach 84.82 B INR.
AUROPHARMA net income for the last quarter is 8.48 B INR, while the quarter before that showed 8.25 B INR of net income which accounts for 2.87% change. Track more Aurobindo Pharma Ltd financial stats to get the full picture.
Aurobindo Pharma Ltd dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.41% and 8.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 8, 2026, the company has 40.75 K employees. See our rating of the largest employees — is Aurobindo Pharma Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aurobindo Pharma Ltd EBITDA is 67.01 B INR, and current EBITDA margin is 20.54%. See more stats in Aurobindo Pharma Ltd financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aurobindo Pharma Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aurobindo Pharma Ltd technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aurobindo Pharma Ltd stock shows the buy signal. See more of Aurobindo Pharma Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.